Category Archives: News

Agicap raises €45m in Series C round

AXA

Agicap, the all-in-one treasury management platform, announces €45m Series C funding round led by AVP

Press release, LYON – November, 12, 2024

The round led by AVP will enable Agicap to further consolidate its leadership position in Europe as it scales to become the global reference in the midmarket treasury management space.

Agicap is pleased to announce a €45m Series C funding round led by AVP.

Since its inception, Agicap has emerged as the leading treasury management platform for SMB and midmarket companies, the driving force of our economy. Agicap provides the C-suite and finance teams with flexible and real-time visibility into current, historical and projected cash flow data, alongside a comprehensive, end-to-end suite of treasury management tools.

Cash management and forecasting have become top priorities for CFOs navigating increasingly uncertain macroeconomic conditions. Yet, Agicap’s recent survey (in partnership with Innofact) of 500 European CFOs revealed that 80% of midmarket firms still rely on Excel-based processes to manage and forecast their cash positions – a manual, time-consuming task with only 41% conducting long-term cash forecasts.

“In today’s economic conditions, the importance of cash management is paramount. Mid-market organizations have reached a level of complexity that makes it challenging for them to properly manage and optimize their cash strategy, given the need to track countless incoming and outgoing cash flows across multiple entities with numerous bank accounts and currencies. Agicap automates this entire process, offering critical insights in just minutes.”
Clément Mauguet, Co-founder & Chief Expansion Officer, Agicap

Agicap empowers more than 8,000 companies by simplifying the consolidation of cash flow data through unique and direct bank connectivity (via local protocols, an extensive network of real-time APIs and Swift) as well as integration with ERPs, finance and other business enablement tools. The platform also offers actionable levers to improve cash performance and simplify liquidity management with optimized payment strategies, customer collections, debt and investment management, spend management and more.

“Midmarket companies lose an average of €450k annually on overdraft fees and financial income due to inefficient cash management. Agicap’s purpose is to bring this figure close to zero.”
Sébastien Beyet, Co-founder & CEO, Agicap

Since its Series B funding in 2021, led by GreenOaks Capital, Agicap has increased its revenue by 7x and solidified its leadership position in Europe by expanding into 4 regions (DACH, Italy, UK & Ireland, Spain), while demonstrating strong efficiency, with the company projected to generate positive cash flow in Europe by beginning of 2025. Agicap has also enhanced its Treasury Management System with new product offerings (such as accounts payable automation, accounts receivable automation and spend management) designed to serve larger midmarket customers as the company scales upmarket.

Agicap will use the Series C funds to continue investing in its product, people, and growth initiatives. The transaction proceeds will support efforts to:

  • Consolidate its leadership in Europe by expanding sales and customer success teams, especially outside of France (other countries already account for >50% of total revenue)
  • Double down on product depth and capabilities by reinforcing its software & organization to better address the unique needs of midmarket firms across the product suite (e.g., FX risk and credit management modules)
  • Strengthen its go-to-market strategy by expanding indirect channels, through the network of treasury partners and system integrators

AVP is excited to support Agicap in its next phase of growth as the lead investor in its Series C round. This marks the first European investment from AVP’s newly created €1.5bn late-stage fund, a vehicle dedicated to supporting high-potential technology scale-ups in Europe and the US.

“We are thrilled to invest in the exceptional team at Agicap as they continue on their path to become the next generation global Treasury Management System. Agicap has the best-in-class technology, deepest product offering with the highest accuracy. We were thoroughly impressed by the product-driven culture, strong customer references, rapid growth and seamless ability to scale in different markets. We look forward to being a long-term partner of Agicap as they continue on their global expansion journey.”
Warda Shaheen, General Partner, AVP

About Agicap

Founded in 2016, Agicap is at the forefront of cash management innovation, with a next-gen treasury management solution integrating Banking & ERP connectivity, Cash Management, Liquidity Planning, Accounts Receivable, Accounts Payable and Spend Management. With over 8,000 clients across Europe, Agicap continues to empower businesses to achieve operational excellence and maintain a culture of cash performance. Learn more at www.agicap.com/en/.
Contact: Bertrand Salord, Chief Marketing Officer (bertrand.salord@agicap.com)

About AVP

AVP is a global venture capital firm specializing in high-growth, technology-enabled companies, managing more than $2 billion in assets across four investment strategies: Venture, Growth, Late Growth, and Fund of Funds. Since its establishment in 2016, AVP has invested in more than 60 technology companies in Venture and Growth stages in the US and Europe. With offices in New York, London, and Paris, AVP supports companies in expanding internationally and provides portfolio companies with tailored business development opportunities to further accelerate their growth. For more information about AVP, please visit www.axavp.com.

Contact: Sébastien Loubry, Partner Business development (sebastien@axavp.com)

Categories: News

Tags:

Blackstone Leads Landmark Music ABS Transaction for Hipgnosis

Blackstone

Hipgnosis completes $1.47 billion music ABS deal, successfully pricing one of the largest-ever music royalty securitisations.

LONDON, UK – Hipgnosis, a leading music rights investment and management company, today announced the successful completion of a $1.47 billion master trust music rights asset-backed securities (ABS) deal, Lyra 24-2.

This landmark transaction represents Hipgnosis Song Assets’ second music royalty securitisation, after a $222 million issuance in 2022. The 2024 deal is backed by royalties from the $2.36 billion music rights portfolio acquired as part of the take-private of Hipgnosis Songs Fund (“SONG”), a UK music royalties investment trust, which comprises 138 catalogues across more than 45,000 songs. The portfolio is one of the highest quality, most diversified, seasoned, publishing-led portfolios at scale in the market, including iconic songs from the Red Hot Chili Peppers, Fleetwood Mac, Journey, The Chainsmokers, Shakira, Bon Jovi, 50 Cent and Eurythmics.

Blackstone has been investing in the music royalties asset class since 2021, and in July 2024, with the SONG transaction, completed one of the largest music take-privates ever, demonstrating continued and strong conviction in the asset class.

MUFG Securities was the structuring lead with Barclays, Goldman Sachs, Fifth Third Securities and SMBC Nikko as joint bookrunner. Blackstone Capital Markets served as a co-manager.

With 25 investors, the order book represents one of the most diversified ABS issuance for music rights to date. The notes are rated A- by KBRA and proceeds from issuance will predominantly be used to repay existing debt in full and support future acquisitions.

Ben Katovsky, Chief Executive Officer of Hipgnosis, and Dan Pounder, Chief Financial Officer of Hipgnosis, said: “We are delighted to announce the successful completion of our second asset-backed securitisation, a significant milestone for Hipgnosis. This achievement not only reinforces the quality and strength of our music catalogue but also enables us to unlock new opportunities for growth and investment.

“Music rights continues to be a fast-growing investable asset class that we are excited to be a leader in as we stay firmly committed to supporting songwriters and artists, and enhancing the legacy and value of our songs through active song management.

“With this ABS refinancing completed, we will continue to work on expanding the investor base with further institutionalisation of the asset class leveraging Hipgnosis’ proprietary technology and data analytics platform across underwriting, monitoring and reporting.”

Qasim Abbas, European Head of Tactical Opportunities, Blackstone, added: “This landmark transaction not only highlights the strength of Hipgnosis’ exceptional catalogue but also reflects our capabilities in providing innovative financial solutions in support of their ongoing growth and success.

“Our partnership underscores the long term, sustainable value we see in music royalties, and we remain excited for the future.”

FTI Consulting served as the backup manager for the transaction, with Citibank acting as trustee. Virtu Global Advisors, LLC provided valuation services, while Latham & Watkins provided legal counsel for the issuer and Paul Weiss, Rifkind, Wharton & Garrison for the noteholders.
 
About Hipgnosis
Hipgnosis is a leading music rights investment and management company. Founded in 2018, Hipgnosis owns and manages a portfolio of over 45,000 songs, from more than 145 catalogues, including many of the most successful and culturally important songs of all time. We create value by enhancing the legacy of our songs, optimising revenue generation, developing our audience and advocating on behalf of songwriters.

About Blackstone
Blackstone is the world’s largest alternative asset manager. We seek to deliver compelling returns for institutional and individual investors by strengthening the companies in which we invest. Our more than $1.1 trillion in assets under management include global investment strategies focused on real estate, private equity, infrastructure, life sciences, growth equity, credit, real assets, secondaries and hedge funds. Further information is available at www.blackstone.com. Follow @blackstone on LinkedIn, X (Twitter), and Instagram.
 
Media Contacts
 
Hipgnosis
Giles Croot
+44 (0)20 4542 1511
mediaenquiries@hipgnosissongs.com

The Outside Organisation
Alan Edwards / Nick Caley
+44 (0)7711 081 843

Blackstone
Rebecca Flower
+44 7918 360372
rebecca.flower@blackstone.com

Categories: News

Tags:

Apollo and Mubadala Extend Multi-Billion-Dollar Partnership Focused on Global Origination Opportunities

Apollo logo

Extension Further Strengthens Apollo’s Capital Solutions Business and Origination Capabilities Across Asset Classes, While Enabling Mubadala to Access a Range of Compelling Investment Opportunities

NEW YORK and ABU DHABI, United Arab Emirates, Nov. 11, 2024 (GLOBE NEWSWIRE) — Apollo (NYSE: APO) and Mubadala Investment Company (“Mubadala”) today announced an extension of their multi-billion-dollar partnership focused on global origination opportunities. The multiple year extension of this partnership, which was first established in 2022, further strengthens Apollo’s Capital Solutions business and ability to originate investment opportunities of scale across asset classes to help meet the growing demand for bespoke private debt and equity financing solutions globally.

Co-President of Apollo Asset Management Jim Zelter said, “We are pleased to extend our partnership with Mubadala, which builds on our strong relationship and several strategic initiatives that we have collaborated on over the past several years. Further enhancing our ability to originate investment opportunities that offer strong risk-adjusted returns is our top priority amid unprecedented demand for large-scale, customized capital solutions, and we believe the platform that the firm has created is particularly well positioned as a financing provider of choice to leading companies.”

Omar Eraiqat, Deputy CEO of the Diversified Investments platform at Mubadala, added, “We share an aligned investment philosophy with Apollo and are pleased to extend our longstanding and strategic partnership with them, which provides us access to Apollo’s differentiated origination ecosystem. We continue to observe a secular shift in corporate financing toward private market execution and believe that this platform will continue to provide a scaled supply of attractive investment opportunities.”

At the firm’s Investor Day in October, Apollo announced a new target of reaching $275 billion of annual origination volumes in the next five years. The firm believes it is uniquely positioned to address the financing needs of large, high quality corporate borrowers while serving as a key capital provider supporting areas including the clean energy transition, power & utilities and digital infrastructure.

Eric Needleman, Partner and Head of Apollo Capital Solutions, said, “Mubadala is among the most sophisticated alternative investors globally, and their continued support of our origination and Capital Solutions business positions us to capitalize on a growing global opportunity set as corporate borrowers increasingly recognize the value of private financing solutions.”

“Mubadala and Apollo have a long-standing and mutually beneficial strategic relationship. Within the credit sector, our partnership commenced more than nine years ago in direct lending,” said Fabrizio Bocciardi, Head of Credit Investments at Mubadala. “This partnership has expanded over time across other private debt asset classes driven by Apollo’s innovative capital solutions and our partnership-oriented approach.”

The partnership extension builds on several recent strategic collaborations between Apollo and Mubadala. The firms formed a $2.5 billion joint venture to co-invest in global private credit opportunities, and Mubadala supported Apollo’s launch of a new middle market lending vehicle, Middle Market Apollo Institutional Private Lending, earlier this year. Apollo also invested in Mubadala’s evergreen solutions strategy as part of the launch of its Mubadala Capital Solutions unit in 2023, and Mubadala anchored the formation of Apollo Strategic Origination Partners in 2020.

Apollo Forward-Looking Statements

This press release contains forward-looking statements that are within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are based on management’s beliefs, as well as assumptions made by, and information currently available to, management. When used in this press release, the words “believe,” “anticipate,” “estimate,” “expect,” “intend,” “target”, “seek,” “aim,” “continue,” “will,” “should,” “could,” or “may,” and variations of such words and similar expressions are intended to identify forward-looking statements. Although management believes that the expectations reflected in these forward-looking statements are reasonable, it can give no assurance that these expectations will prove to have been correct. These statements are subject to certain risks, uncertainties and assumptions, including those described under the section entitled “Risk Factors” in Apollo Global Management, Inc.’s annual report on Form 10-K filed with the Securities and Exchange Commission (the “SEC”) on February 27, 2024, and the quarterly report on Form 10-Q filed with the SEC on August 8, 2024, as such factors may be updated from time to time in its periodic filings with the SEC, which are accessible on the SEC’s website at www.sec.gov. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this press release and in Apollo’s other filings with the SEC. Apollo undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise, except as required by applicable law. This press release does not constitute an offer of any Apollo fund.

About Apollo

Apollo is a high-growth, global alternative asset manager. In our asset management business, we seek to provide our clients excess return at every point along the risk-reward spectrum from investment grade credit to private equity. For more than three decades, our investing expertise across our fully integrated platform has served the financial return needs of our clients and provided businesses with innovative capital solutions for growth. Through Athene, our retirement services business, we specialize in helping clients achieve financial security by providing a suite of retirement savings products and acting as a solutions provider to institutions. Our patient, creative, and knowledgeable approach to investing aligns our clients, businesses we invest in, our employees, and the communities we impact, to expand opportunity and achieve positive outcomes. As of September 30, 2024, Apollo had approximately $733 billion of assets under management. To learn more, please visit www.apollo.com.

About Mubadala Investment Company

Mubadala Investment Company is a sovereign investor managing a global portfolio, aimed at generating sustainable financial returns for the Government of Abu Dhabi.

Mubadala’s $302 billion (AED 1,111 billion) portfolio spans six continents with interests in multiple sectors and asset classes. We leverage our deep sectoral expertise and long-standing partnerships to drive sustainable growth and profit, while supporting the continued diversification and global integration of the economy of the United Arab Emirates.

For more information about Mubadala Investment Company, please visit: www.mubadala.com

Contacts:

For Apollo:
Noah Gunn
Global Head of Investor Relations
Apollo Global Management, Inc.
(212) 822-0540
IR@apollo.com

Joanna Rose
Global Head of Corporate Communications
Apollo Global Management, Inc.
(212) 822-0491
Communications@apollo.com

For Mubadala Investment Company:
Salam Kitmitto
Head of Communications – Diversified Investments
Mubadala Investment Company
+971 50 276 9286
sakitmitto@mubadala.ae

Categories: News

Tags:

819 Capital Partners invests in CiMaas to transform cancer treatment

Deventer, November 22, 2024 – 819 Capital Partners has acquired and invested in CiMaas, a biotech company dedicated to developing Natural Killer cell therapy to improve cancer treatment and patient outcomes.

Pioneering Immunotherapy Solutions for Advanced Cancer Treatment

Founded in 2015, CiMaas BV is a spin-off from Maastricht University and Maastricht University Medical Center+ (UM/Maastricht UMC+). CiMaas is transforming cancer treatment by developing innovative immunotherapies that harness the body’s immune system to address unmet needs in metastatic and late-stage cancers. Current therapies cure only 60% of patients in the Western world and often fail in advanced cases.

CiMaas focuses on safe, effective solutions that minimize side effects while enhancing quality of life. By integrating multiple components of the immune system, CiMaas aims to deliver more robust, lasting treatments—bringing new hope to patients.

For collaborations with partners, (non-) GMP-grade feeder cells are now also available. These make it possible to let Natural Killer expand sufficiently, so that sufficient numbers of these cells can be produced for both scientific research and treatment of patients. Furthermore, CiMaas aims to have clinical production ready for Natural Killer cells soon to start clinical research in collaboration with various partners.

Gerard Bos, CEO, CiMaas

“We are pleased to partner with 819 Capital Partners. This investment enables us to continue working on our ambitions: cure cancer patients by making Natural Killer cells a reality. Our commitment to advancing cell-therapy opportunities for cancer treatment remains as strong as ever, and we are very motivated to continue our work in this vital field now In the coming period, we will further strengthen our team with highly skilled professionals.”

Thomas Smit, director 819 Capital Partners

“We are delighted to welcome CiMaas to 819 Evergreen Fund I. Our investment in CiMaas perfectly aligns with our vision to accelerate the growth of cutting-edge ventures. CiMaas’ pioneering technology has great potential and could be a transformative breakthrough in cancer treatment in the future.”

About CiMaas

CiMaas focuses on the development of immunotherapies for specific types of cancer. The company specializes in creating innovative products based on immune system cells, and antibodies. It has created a platform technology using feeder cells for efficient expansion of NK cells.  Founded in 2015, CiMaas BV is a spin-off from Maastricht University and Maastricht University Medical Center+ (UM/Maastricht UMC+). For more information: https://cimaas.com/

819 Capital Partners

819 Capital Partners is an investment firm managing multiple funds with targeted investment strategies. 819 Evergreen Fund takes minority stakes in early-stage deep-tech and med-tech startups, while 819 Private Equity Fund acquires controlling stakes in mature firms within the leisure, IT, and healthcare industries. The open-ended structure of their funds allows for long-term investments with flexible exit timelines. The firm focuses on sectors like healthcare, technology, and leisure, addressing societal challenges such as aging populations.

Categories: News

Tags:

Accelerating Growth for Big Brand Marketing Leader: Our Investment in Omne

Yfm Equity

Accelerating Growth for Big Brand Marketing Leader: Our Investment in Omne

Investment: Omne

Investment Type: MBO

Investment Amount: £8.7m

Sector: Marketing Services

Establishing a leading reputation in the highly competitive arena of food, beverage and hospitality marketing requires a stand-out level of expertise.

When it comes to B2B marketing, big brands need proven, specialist skills and knowledge to help them forge and grow stakeholder relationships. In an industry that is worth billions to the global economy (the global food service market size alone is projected to grow from USD 3,486.58 billion in 2024 to USD 6,348.75 billion by 2032*) agencies that support big brands in helping to gain a greater share of their markets are set to excel.

This has certainly been the case for new YFM investee business, Omne – a marketing agency that has carved out a position as a strategic and creative partner to the world’s best food, beverage, foodservice and hospitality brands.

Headquartered in Ampthill, Bedfordshire, Omne has developed a global client base since its founding in 2001, servicing major names such as Unilever, Kelloggs and Tate & Lyle.

Now, having secured YFM’s backing for a management buyout, Omne is embarking on the next chapter of its success story. The £8.7 million investment will help the company to enhance its team of expert marketers and pursue further growth through new customer wins.

Omne’s appeal lies in its deep expertise, driven team and excellent track record.

Stand out expertise

Omne is built on a foundation of unrivalled expertise in the food, beverage and hospitality markets. Offering end-to-end strategic consulting, market insights, brand/creative campaigns, content/influencer marketing, specialist trade communications and an incentive/rewards software solution, Omne’s integrated approach is designed to generate demand, change behaviour and drive ROI.

With a multi-skilled and immersed team on board, Omne is perfectly positioned to understand the challenges faced by its clients and to help them achieve their objectives.

Ambitious leadership

Omne’s MBO is being led by incumbent CEO, Michael Gividen, who has been with the business since its inception.

Along with the rest of the management team, who are well embedded within their niche and driving the success of this high-calibre, high profile agency, Michael is committed to accelerating Omne’s growth plans. Utilising YFM’s capital, Omne’s leadership will now galvanise the company’s uniquely skilled team and build the capacity needed to secure more prestigious client wins.

Big brand relationships

Omne counts some of the world’s largest food and beverage brands amongst its clients. In the years since its founding the business has fostered long-term strategic and creative partnerships with big brands here in the UK and internationally. Omne’s relationship with Unilever, which has been a core client from the agency’s conception, is testament to Omne’s results-driven, collaborative approach.

Going forward, Omne will apply its successful client formula to target new growth and new customer wins, with YFM’s support.

*Source: https://www.fortunebusinessinsights.com/food-service-market-106277

Categories: News

Tags:

MDC Announces the Acquisition of Lighteum: Strengthening Leadership in Precision Medical Components Manufacturing

Montagu

MDC (Medical Device Components), a leading global provider of high-precision, minimally invasive medical device components, today announced its acquisition of Lighteum, a pioneer in nitinol-based medical component manufacturing. The acquisition closed on November 8, 2024.

This strategic acquisition brings together MDC’s long-standing expertise in platinum group metals and advanced micromachining with Lighteum’s cutting-edge capabilities in nitinol processing, which span high-throughput laser cutting, laser welding, heat shaping and electropolishing. The combination of these complementary technologies will enable MDC to further expand its portfolio and better serve the evolving needs of the medical device industry.

This acquisition demonstrates our commitment to continuous innovation.

Don Freeman, CEO, MDC

“We are excited to welcome Lighteum into the MDC family,” said Don Freeman, CEO of MDC. “By combining our capabilities, we will be able to offer our customers an unparalleled range of services, from prototyping through high-volume production. This acquisition demonstrates our commitment to continuous innovation and positions us to deliver more comprehensive solutions, improving patient outcomes worldwide.”

Lighteum will enhance MDC’s front-end capabilities in design and development.

Adrien Sassi, Partner, Montagu

Adrien Sassi, Partner at Montagu, commented: “We are thrilled to support MDC on this initial acquisition, following the successful carve-out of the business in July, and we warmly welcome the Lighteum team. Lighteum will enhance MDC’s front-end capabilities in design and development, helping companies innovate and accelerate the launch of life-saving medical devices.”

Lighteum, known for its rapid prototyping and transparent customer collaboration, has set itself apart as a nimble and flexible partner in the medical device industry. With the backing of MDC’s global infrastructure and extensive R&D and manufacturing resources, the combined company will be uniquely positioned to accelerate innovation, helping medical device companies bring their life-saving technologies to market faster and with even greater precision.

The combination of MDC’s leadership in precious metal components and nitinol fabrication, with Lighteum’s expertise in nitinol process development, will push the boundaries of what’s possible in medical device manufacturing.

Jose Maeso, CTO, Lighteum

“This acquisition enables us to expand Lighteum’s white-glove customer service and quick-turn responsiveness to a global customer base,” said Lorie Lodico IV, COO of Lighteum. “The combination of MDC’s leadership in precious metal components and nitinol fabrication, with Lighteum’s expertise in nitinol process development, will push the boundaries of what’s possible in medical device manufacturing,” added Jose Maeso, CTO of Lighteum.

Together, MDC and Lighteum will continue to provide world-class customer support and ensure supply chain stability, expanding their manufacturing capabilities in San Diego, Mexicali, Australia and globally. By merging their strengths, the combined company will deliver cutting-edge solutions that meet the increasing complexity of medical device design.

The integration of Lighteum’s team and operations began immediately following the close of the acquisition.

About MDC
MDC is a global leader in the development and manufacture of precision medical components, specializing in platinum group metals, nitinol, and advanced coatings. With decades of expertise in metallurgy and micromachining, MDC serves the world’s leading medical device companies, helping them bring cutting-edge technologies to market with speed and reliability.

About Lighteum
Lighteum is a manufacturer of high-complexity nitinol-based medical components, focused on transforming customer experience through transparency and best-in-class innovation. Their core capabilities include femtosecond laser processing, heat shaping, and electropolishing technologies, serving the medical device market. Covington Associates served as exclusive financial advisor to Lighteum for this transaction.

Categories: News

Tags:

SHIFT Invest Portfolio Company Robin Radar Joins Forces with Parcom

Shift Invest

SHIFT Invest is pleased to announce the successful acquisition of its portfolio company, Robin Radar, by Dutch investor Parcom. Robin Radar has established itself as a global leader in radar systems designed to detect and classify both birds and drones.

SHIFT Invest Portfolio Company Robin Radar Joins Forces with Parcom

 

Robin Radar, headquartered in The Hague, Netherlands, founded in 2010 as a TNO spin-off, has established itself as a global leader in radar systems designed to detect and classify birds and drones. The company’s radar solutions serve a range of industries such as wind farms and civil aviation providing an innovative solution to reduce bird strikes. Robin Radar’s unique technology, particularly its proprietary software, has made it the radar solution of choice for a diverse range of applications.

SHIFT Invest joined Robin Radar as lead investor together with INKEF in its first funding round in 2012. The investment was made through its first fund Mainport Innovation Fund backed by KLM, Schiphol Airport, TU Delft, Rabobank and RVO. Robin Radar’s story is truly exceptional: from securing Schiphol as a launching customer, to growing revenues 30-fold since the initial investment by SHIFT Invest.

Siete Hamminga, CEO of Robin Radar: “We are thankful for the valuable collaboration with SHIFT Invest throughout our entire growth journey. Guus Verhees served as chairman of the board and supported us in growing our leadership team and organization, follow-on investments and the process towards the new partnership with Parcom”.

Guus Verhees, Managing Partner of SHIFT Invest: “We want to congratulate the entire team at Robin Radar, who have built an incredible technology and company over the years. The Robin Radar team, now with over 150 people, worked hard to make this possible, and we are happy to see Parcom partnering up to facilitate the next phase of growth. This is a great Dutch success story of an innovative technology bringing value in various sectors with a new growth chapter ahead.”

Categories: News

Agro Care wins first prize in prestigious Hillenraad100 competition

NPM Capital

Agro Care wins first prize in prestigious Hillenraad100 competition

Poeldijk – This year, NPM-participation Agro Care won first prize in the Hillenraad100 selection, a list of the top 100 leading horticulture companies put together each year by the horticulture consultancy firm of Hillenraad. The reviewers evaluate the participants based on their strategy, market position, growth and innovation, sustainability, organisation, performance, and entrepreneurial vision.

 

Roughly 1% of the Dutch horticulture sector, which in turn represents the top layer of the global horticultural sector, is selected for the prestigious Hillenraad100 list. According to the jury panel of professionals, Agro Care exemplifies as no other how the horticulture sector is changing and becoming ever bigger and more international. The fact that Agro Care stood at number 100 on the first ever list put together 20 years ago makes it even more special that in won first prize this time around. In the category of performance, Agro Care also placed first so that it ended up going home with two prizes.

 

NPM Capital was also present on the podium during the event in The Hague, but it was there to present an award. NPM awarded the Long Term Leadership Award to the winner of the all-time top 100 selection, which was created to celebrate the anniversary of the Hillenraad100 competition. The prize was awarded to the Dutch Flower Group, which had the highest average scores over the years.

Categories: News

Tags:

CVC Credit prices tenth new issue CLO of the year with $500m Apidos L (50)

CVC Capital Partners

NEW YORK – CVC Credit, the $45bn global credit management business of CVC, is pleased to announce that it has successfully priced Apidos L (50), a new $500m (c.€460m) Collateralized Loan Obligation (“CLO”). Apidos L (50) is CVC Credit’s tenth new issue CLO pricing globally this year.

Apidos L (50) has a five-year reinvestment period and two-year non-call period that is supported by an actively managed, diversified portfolio of senior secured loans and bonds. The portfolio was more than two thirds ramped on pricing date. Jefferies acted as lead arranger.

Apidos L (50) is also the fifth new CLO vehicle priced in North America in the year to date. Combined these vehicles have a combined value of $2.0bn (c.€1.9bn).

Cary Ho, Partner and Global Head of CLO Origination at CVC Credit, said: “Apidos L (50) was very well received by the market and our broad investor base. It has been a busy year in the U.S. CLO market, where new issuance, refinancings and reissuance volumes have remained high. At CVC we have taken advantage of this, pricing five new U.S. CLOs and with significant refinancing and reset activity to enhance value in our existing portfolios.”

Quotes

We appreciate the strong support we continue to receive from our valued investor base following the pricing of our tenth new CLO globally this year.

Gretchen BergstresserManaging Partner and Global Head of Performing Credit at CVC Credit

Gretchen Bergstresser, Managing Partner and Global Head of Performing Credit at CVC Credit, added: “We appreciate the strong support we continue to receive from our valued investor base following the pricing of our tenth new CLO globally this year. Our team remains committed to delivering consistent performance through all of our CLOs actively managed, scalable and diversified pool of senior-secured floating rate loans.”

CVC Credit has nearly 20 years of experience in successful CLO issuance, performing credit and active portfolio management, with proven experience in delivering attractive risk-adjusted performance through varied credit market cycles.

Categories: News

Friday Energy secures investment from SHIFT Invest to help businesses operate more sustainably and mitigate power grid constraints

Shift Invest

Utrecht, The Netherlands – SHIFT Invest anounces an investment in Friday Energy, a Utrecht-based company offering smart storage solutions to businesses facing grid constraints. With this investment, Friday aims to take a big step towards their mission to give everyone access to 100% sustainable and affordable energy.

 

 

Friday Energy aims to accelerate the energy transition with smart battery storage and advanced energy control software. Their solutions optimise renewable energy sources such as solar and wind power, reduce costs and ease the load on the grid. Friday Energy delivers solutions for businesses by increasing revenue on renewable assets and doing business sustainably.

“The investment enables us to realise our growth plans and we are one step further in achieving our mission: access to sustainable and affordable energy for all and accelerating the energy transition through efficient use of flexible power. Our advanced software and IT solutions for energy management of energy storage systems are essential for this.” Bouke Siebenga, CEO – Friday Energy.

“We believe innovation and entrepreneurship are essential to restore the balance between nature and society. In doing so, we contribute to the transition to a more sustainable world. We are impressed by the energy storage solution Friday Energy has developed and are proud that Friday Energy, with the help of our investment, can accelerate the achievement of their mission. ” Koen Hooning, Associate Partner – SHIFT Invest

Categories: News